Iran Daru (XTEH:IRDR1) EBITDA Margin % : 0.00% (As of . 20)

View and export this data going back to 1990. Start your Free Trial

What is Iran Daru EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Iran Daru's EBITDA for the six months ended in . 20 was IRR0.00 Mil. Iran Daru's Revenue for the six months ended in . 20 was IRR0.00 Mil. Therefore, Iran Daru's EBITDA margin for the quarter that ended in . 20 was 0.00%.

Iran Daru EBITDA Margin % Historical Data

The historical data trend for Iran Daru's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Iran Daru EBITDA Margin % Chart

Iran Daru Annual Data

Trend

EBITDA Margin %

Iran Daru Semi-Annual Data

EBITDA Margin %

Competitive Comparison of Iran Daru's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Iran Daru's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Iran Daru's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Iran Daru's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Iran Daru's EBITDA Margin % falls into.

Iran Daru EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Iran Daru's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %	=	EBITDA (A: . 20 )	/	Revenue (A: . 20 )
	=		/
	=	%

Iran Daru's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %	=	EBITDA (Q: . 20 )	/	Revenue (Q: . 20 )
	=		/
	=	%

Iran Daru (XTEH:IRDR1) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Iran Daru EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Iran Daru's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Iran Daru (XTEH:IRDR1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Iran Daru (XTEH:IRDR1) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ayatollah Saeedi Highway, End Of Kermani Street, Moallem Boulevard, Tehran, IRN, 1371658111

Website

https://www.irandaru.com

Iran Daru is a pharmaceutical company based in Iran. It manufactures and sells pharmaceutical products for antibiotics, cardiovascular agents, and local anesthetic agents. The company manufactures products in three main dosage form categories namely solid, semi-solid, and liquid including tablets, capsules, pellets, sachets, gels, creams, ointments (sterile and non-sterile), spray solutions, and syrups. Products offered by Iran Daru include Diclofenac Potassium, Biotin 5 mg, Tetracycline, Folic acid, Meloxicam, Acetaminophen and Caffeine, and Levocetirizine dihydrochloride, among others. It also exports its products to other countries.

Iran Daru (XTEH:IRDR1) Headlines

No Headlines